Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic’s VenaSeal Closure System Receives FDA Approval For Treating Chronic Venous Disease

Executive Summary

Adding to its product portfolio for treating superficial venous reflux, Medtronic has now received US approval for a more minimally invasive device, the VenaSeal closure system, which uses adhesive injections to seal the diseased vein in select patients with chronic venous insufficiency. Superficial venous reflux can lead to symptomatic varicose veins.


Related Content


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts